Related references
Note: Only part of the references are listed.High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals
Masaki Hirashima et al.
JOURNAL OF BIOCHEMISTRY (2016)
High-yield preparation of recombinant human α-thrombin for therapeutic use
Akihiro Meta et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2015)
Association Between Hospital Intraoperative Blood Transfusion Practices for Surgical Blood Loss and Hospital Surgical Mortality Rates
Wen-Chih Wu et al.
ANNALS OF SURGERY (2012)
Massive bleeding: Are we doing our best?
Marco Marietta et al.
TRANSFUSION AND APHERESIS SCIENCE (2011)
Efficacy of TachoSil a fibrin-based haemostat in different fields of surgery- a systematic review
Andreas Rickenbacher et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Improvement of the Tissue-adhesive and Sealing Effect of Fibrin Sealant Using Polyglycolic Acid Felt
Noriko Shinya et al.
JOURNAL OF INVESTIGATIVE SURGERY (2009)
Achieving Hemostasis in the Surgical Field
Bradley A. Boucher et al.
PHARMACOTHERAPY (2009)
Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant
Benjamin J. Kober et al.
ANESTHESIA AND ANALGESIA (2008)
Hemostats, sealants, and adhesives: components of the surgical toolbox
William D. Spotnitz et al.
TRANSFUSION (2008)
Topical Hemostatic Agents in Surgery: A Surgeon's Perspective
Srinath Samudrala
AORN JOURNAL (2008)
Pathophysiology of bleeding in surgery
M. Marietta et al.
TRANSPLANTATION PROCEEDINGS (2006)
Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery
M Kawamura et al.
ANNALS OF THORACIC SURGERY (2002)
Share Paper
